Literature DB >> 22814792

Stressors and rheumatoid arthritis: changes in stressors with advances in therapeutic agents.

Tomoko Otake1, Mutsumi Ashihara, Jo Nishino, Kenichi Kato, Shusaku Fukaya, Shunji Yoshida.   

Abstract

The significance of evaluations of stressors in rheumatoid arthritis (RA) patients was investigated from the perspective of holistic medicine. The subjects were RA patients treated in the rheumatology outpatient clinic. They included 30 patients from 1987, 30 from 2002, and 137 from 2009. To investigate the specific causes of stress, the patients were asked the question, "What do you feel is your strongest stressor?" The same patients also underwent psychological testing and was examined the disease activity. Pain was the strongest stressor in RA patients in 1987, 2002, and 2009. However, the percentage of patients citing pain as their major stressor was decreasing with each year. CRP was significantly lower in 2009 than in 2002. CRP was also significantly lower in patients who used biologics than in patients who did not. In 2009, DAS28-CRP was significantly higher in patients whose largest stressor was pain than in patients whose largest stressor was another factor. In 2009, the values for both state anxiety and trait anxiety were significantly higher in patients who said that they had stressors than in those who said they did not. The strongest stressor in RA patients was pain. However, the percentage decreased over the years with lower disease activity from advances in therapeutic agents such as biologics. Meanwhile, stressors other than pain were the same or somewhat increased, and they were related to anxiety or depression. Understanding stressors in RA is thus important in treating RA patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22814792     DOI: 10.1007/s00296-012-2457-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

1.  Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study.

Authors:  T P Suurmeijer; M Waltz; T Moum; F Guillemin; F L van Sonderen; S Briançon; R Sanderman; W J van den Heuvel
Journal:  Arthritis Rheum       Date:  2001-04

2.  Psychological issues in the management of rheumatoid arthritis.

Authors:  D J Zeitlin
Journal:  Psychosomatics       Date:  1977-08       Impact factor: 2.386

3.  Perceived stressors and coping strategies among individuals with rheumatoid arthritis.

Authors:  G Mahat
Journal:  J Adv Nurs       Date:  1997-06       Impact factor: 3.187

4.  Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Authors:  Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; C F Allaart; D van Zeben; P J S M Kerstens; J M W Hazes; A H Zwinderman; H K Ronday; K H Han; M L Westedt; A H Gerards; J H L M van Groenendael; W F Lems; M V van Krugten; F C Breedveld; B A C Dijkmans
Journal:  Arthritis Rheum       Date:  2005-11

5.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

Review 6.  [Stress and rheumatoid arthritis].

Authors:  O Malysheva; M Pierer; U Wagner; C G O Baerwald
Journal:  Z Rheumatol       Date:  2010-08       Impact factor: 1.372

7.  Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.

Authors:  R N Maini; F C Breedveld; J R Kalden; J S Smolen; D Furst; M H Weisman; E W St Clair; G F Keenan; D van der Heijde; P A Marsters; P E Lipsky
Journal:  Arthritis Rheum       Date:  2004-04

8.  Stress caused by rheumatoid arthritis: relation among subjective stressors of the disease, disease status, and well-being.

Authors:  W van Lankveld; G Näring; C van der Staak; P van 't Pad Bosch; L van de Putte
Journal:  J Behav Med       Date:  1993-06

Review 9.  Quality-of-life assessment in rheumatoid arthritis.

Authors:  Anthony S Russell
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 10.  Stress as a trigger of autoimmune disease.

Authors:  Ljudmila Stojanovich; Dragomir Marisavljevich
Journal:  Autoimmun Rev       Date:  2007-11-29       Impact factor: 9.754

View more
  1 in total

1.  Epigallocatechin-3-gallate reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice induced with adenomyosis.

Authors:  Yumei Chen; Bo Zhu; Hongping Zhang; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Sci       Date:  2013-05-23       Impact factor: 3.060

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.